29 results
S-3
EX-4.2
OTLK
Outlook Therapeutics Inc
Shelf registration
28 Mar 24
5:01pm
S-3
EX-4.4
OTLK
Outlook Therapeutics Inc
Shelf registration
28 Mar 24
5:01pm
S-3
EX-4.5
OTLK
Outlook Therapeutics Inc
Shelf registration
28 Mar 24
5:01pm
S-3
EX-4.6
OTLK
Outlook Therapeutics Inc
Shelf registration
28 Mar 24
5:01pm
8-K
EX-4.2
OTLK
Outlook Therapeutics Inc
24 Jan 24
Entry into a Material Definitive Agreement
6:02am
8-K
EX-4.1
zeo81lq m9suhe3hui
24 Jan 24
Entry into a Material Definitive Agreement
6:02am
8-K
EX-4.1
y020dgx1du
23 Dec 22
Outlook Therapeutics Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:03pm
8-K
EX-4.1
g97475snt
29 Nov 21
Outlook Therapeutics Announces $10 Million Bought Deal Offering of Common Stock
5:00pm
8-K
EX-4.1
jpo5iefdetjm ejphk09
2 Feb 21
Outlook Therapeutics Announces $10.0 Million Bought Deal Offering of Common Stock
5:21pm
8-K
EX-4.1
ogg26mc
23 Jun 20
Outlook Therapeutics Announces $11.2 Million Financings Priced At-The-Market Under Nasdaq Rules
4:56pm
8-K
EX-4.1
qqhu0c
24 Feb 20
Outlook Therapeutics Announces $10.2 Million Financings Priced At-The-Market
5:11pm
8-K
EX-4.2
gvbnc9fqcp e9m
24 Feb 20
Outlook Therapeutics Announces $10.2 Million Financings Priced At-The-Market
5:11pm
8-K
EX-4.3
1f1hf37l pkb
24 Feb 20
Outlook Therapeutics Announces $10.2 Million Financings Priced At-The-Market
5:11pm